Company intelligence / Profile preview

Ergomed Clinical Research

Guildford, Surrey, United Kingdom

Ownership: Private
Employees: ~1400
Development stage: Other

Overview

Ergomed has managed over 600 trials globally, with a focus on oncology, rare diseases, and complex therapeutic areas, including advanced modalities such as cell and gene therapy, accumulating extensive experience in successful trial execution for challenging indications.

Therapeutic areas: HematologyImmunologyNephrologyCardiovascularEndocrinologyNeurologyDermatologyInfectious DiseasesPulmonologyRare DiseasesGastroenterologyMetabolic DisordersOncology
Modalities: Small moleculeMonoclonal antibodyTri-functional antibodySoluble receptorCancer vaccineImmunotherapyRadiopharmaceuticalPhotodynamic therapyBiologicCell therapyGene therapyOncolytic virus therapy
Industry: Contract Research Organization

Beyond the preview

Go deeper on Ergomed Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ergomed Clinical Research.

Explore the full profile